CHELSI MARTIN: Open Payments
NPI 1104577931 · LEAWOOD, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 5 payments from 4 companies in 2025. Trend: 2023 $780 · 2024 $108 · 2025 $100
Food & beverage: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Genentech USA, Inc. | 1 | $26 |
| Smith+Nephew, Inc. | 1 | $24 |
| Melinta Therapeutics, LLC | 1 | $14 |
Products named: Xolair, COLLAGENASE SANTYL, Rezzayo.
Industry payments across KS — which companies pay providers there.
